Progressive loss of antiemetic efficacy during subsequent courses of chemotherapy
- 31 March 1992
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 28 (2-3) , 430-432
- https://doi.org/10.1016/s0959-8049(05)80069-3
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Protection from nausea and vomiting in cisplatin-treated patients: high-dose metoclopramide combined with methylprednisolone versus metoclopramide combined with dexamethasone and diphenhydramine: a study of the Italian Oncology Group for Clinical Research.Journal of Clinical Oncology, 1989
- Combination antiemetics for cisplatin chemotherapyCancer, 1988
- Clinical evaluation of the simultaneous blockade of the dopamine D-2, Histamine H-1, and muscarinic cholinergic receptors in cancer chemotherapy-induced emesis: Results of a controlled trialCancer Chemotherapy and Pharmacology, 1986
- Maintenance of Antiemetic Effect of a Metoclopramide-Dexamethasone Combination during Subsequent Cisplatin CoursesOncology, 1986